Review
Published on 06 Jun 2022
Vitamin D: A Potential Star for Treating Chronic Pancreatitis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.902639
- 4,974 views
- 4 citations
Type at least 3 characters
971 articles
Articles
Original Research
Published on 02 Jun 2022
Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.908128
- 3,665 views
- 6 citations
Original Research
Published on 02 Jun 2022
Emodin Ameliorates Acute Pancreatitis-Associated Lung Injury Through Inhibiting the Alveolar Macrophages Pyroptosis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.873053
- 3,813 views
- 4 citations
Original Research
Published on 02 Jun 2022
Dihydromyricetin-Encapsulated Liposomes Inhibit Exhaustive Exercise-Induced Liver Inflammation by Orchestrating M1/M2 Macrophage Polarization
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.887263
- 3,213 views
- 1 citation
Review
Published on 02 Jun 2022
Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.871100
- 3,187 views
- 7 citations
Original Research
Published on 01 Jun 2022
Kaempferol Inhibits Hepatic Stellate Cell Activation by Regulating miR-26b-5p/Jag1 Axis and Notch Pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.881855
- 2,570 views
- 10 citations
Original Research
Published on 31 May 2022
Inflammatory-Dependent Bidirectional Effect of Bile Acids on NLRP3 Inflammasome and Its Role in Ameliorating CPT-11-Induced Colitis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.677738
- 2,867 views
- 5 citations
Original Research
Published on 31 May 2022
Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.881231
- 2,937 views
- 5 citations
Review
Published on 31 May 2022
Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.919567
- 4,183 views
- 4 citations
Original Research
Published on 26 May 2022
Disordered Gut Microbiota in Colorectal Tumor-Bearing Mice Altered Serum Metabolome Related to Fufangchangtai
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.889181
- 2,927 views
- 1 citation
Original Research
Published on 25 May 2022
Saikosaponin d Alleviates Liver Fibrosis by Negatively Regulating the ROS/NLRP3 Inflammasome Through Activating the ERβ Pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.894981
- 3,832 views
- 8 citations
Original Research
Published on 24 May 2022
Rhoifolin Alleviates Alcoholic Liver Disease In Vivo and In Vitro via Inhibition of the TLR4/NF-κB Signaling Pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.878898
- 2,452 views
- 6 citations
Original Research
Published on 20 May 2022
Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.896198
- 1,688 views
- 3 citations
Original Research
Published on 20 May 2022
Miya Improves Osteoarthritis Characteristics via the Gut-Muscle-Joint Axis According to Multi-Omics Analyses
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.816891
- 2,629 views
- 1 citation
Original Research
Published on 19 May 2022
Ferulic Acid Combined With Bone Marrow Mesenchymal Stem Cells Attenuates the Activation of Hepatic Stellate Cells and Alleviates Liver Fibrosis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.863797
- 2,307 views
- 1 citation
Original Research
Published on 19 May 2022
Mendelian Randomization Rules Out Causation Between Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.891410
- 11,094 views
- 2 citations